Speakers

Molly joined Albion in 2022, focusing on opportunities in health tech and digital pharma. Before that she was at McKinsey & Co covering healthcare systems, services and technologies. Prior to McKinsey, Molly was Chief Commercial Officer of Induction Healthcare Group, which completed an IPO on AIM in 2019, and a founding team member of Pando, a messaging and workflow tool for doctors.

Molly holds a degree in Medicine & Surgery, and a BA in Molecular Medicine, from Oxford University.